AlloVir, Inc. (ALVR)
NASDAQ: ALVR · IEX Real-Time Price · USD
0.742
-0.015 (-1.96%)
At close: Apr 18, 2024, 4:00 PM
0.750
+0.008 (1.06%)
After-hours: Apr 18, 2024, 7:56 PM EDT
AlloVir Market Cap
AlloVir has a market cap or net worth of $84.65 million as of April 18, 2024. Its market cap has decreased by -74.49% in one year.
Market Cap
84.65M
Enterprise Value
-72.72M
1-Year Change
-74.49%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since July 30, 2020, AlloVir's market cap has decreased from $1.55B to $84.65M, a decrease of -94.55%. That is a compound annual growth rate of -54.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 18, 2024 | 85.20M | -2.07% |
| Apr 17, 2024 | 87.00M | 3.08% |
| Apr 16, 2024 | 84.40M | -1.52% |
| Apr 15, 2024 | 85.70M | -2.72% |
| Apr 12, 2024 | 88.10M | -0.68% |
| Apr 11, 2024 | 88.70M | 2.78% |
| Apr 10, 2024 | 86.30M | 0.94% |
| Apr 9, 2024 | 85.50M | 0.94% |
| Apr 8, 2024 | 84.70M | -1.28% |
| Apr 5, 2024 | 85.80M | -1.72% |
| Apr 4, 2024 | 87.30M | -1.02% |
| Apr 3, 2024 | 88.20M | 0.11% |
| Apr 2, 2024 | 88.10M | -4.76% |
| Apr 1, 2024 | 92.50M | 6.69% |
| Mar 28, 2024 | 86.70M | -0.80% |
| Mar 27, 2024 | 87.40M | 1.39% |
| Mar 26, 2024 | 86.20M | -1.26% |
| Mar 25, 2024 | 87.30M | 1.04% |
| Mar 22, 2024 | 86.40M | -2.48% |
| Mar 21, 2024 | 88.60M | 3.50% |
| Mar 20, 2024 | 85.60M | -0.12% |
| Mar 19, 2024 | 85.70M | 1.90% |
| Mar 18, 2024 | 84.10M | -6.03% |
| Mar 15, 2024 | 89.50M | 7.96% |
| Mar 14, 2024 | 82.90M | -0.12% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 111, Inc. | 86.77M |
| Forian | 86.24M |
| CEL-SCI | 85.83M |
| Aclaris Therapeutics | 85.82M |
| Curis | 85.82M |
| PMV Pharmaceuticals | 84.11M |
| Affimed | 83.60M |
| Protalix BioTherapeutics | 83.28M |